Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance

Antiviral Research

Volumn 89, Issue 3, 2011, Pages 227-231

  Wang, Yu Ping ^a   Zhao, Wei ^b   Xue, Rong ^b   Zhou, Zhen Xian ^b   Liu, Fei ^a   Han, Yan Xing ^a   Ren, Gang ^a   Peng, Zong Gen ^a   Cen, Shan ^a   Chen, Hong Shan ^a   Li, Yu Huan ^a   Jiang, Jian Dong ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b Nanjing Second Hospital   (China)

Author keywords

Antiviral therapy; Drug resistance; Hepatitis B virus; Hsc70; Oxymatrine

Indexed keywords

LAMIVUDINE; MESSENGER RNA; OXYMATRINE; VIRUS DNA;

ADULT; ARTICLE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

ADMINISTRATION, ORAL; ADULT; ALKALOIDS; ANTIVIRAL AGENTS; BIOPSY; CHINA; DNA, VIRAL; DOWN-REGULATION; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HSC70 HEAT-SHOCK PROTEINS; HUMANS; LAMIVUDINE; LIVER; MALE; MIDDLE AGED; QUINOLIZINES; TREATMENT OUTCOME; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 79951584353     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.01.005     Document Type: Article

References (25)

1. Bock C.T., Schranz P., Schröder C.H., Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994, 8:215-229.
2. Cai X., Wang G.J., Qu Y., Fan C.H., Zhang R.Q., Xu W.S. Clinical efficacy of oxymatrine in the treatment of chronic hepatitis B. Acad. J. Sec. Mil. Med. Univ. 1997, 18:47-49.
3. Chen Y.J., Chen Y.H., Chow L.P., Tsai Y.H., Chen P.H., Huang C.Y., Chen W.T., Hwang L.H. Heat shock protein 72 is associated with the hepatitis C virus replicase complex and enhances viral RNA replication. J. Biol. Chem. 2010, 285:28183-28190.
4. Chen Z.X., Zhang S.J., Lao S.X., Hu H.T., Zhang C.Y., Guan S.H., Gu Y.L. He Jie Tang in the treatment of chronic hepatitis B patients. World J. Gastroenterol. 2005, 11:6638-6643.
5. Delfraissy J.F., Flandre P., Delaugerre C., Ghosn J., Horban A., Girard P.M., Norton M., Rouzioux C., Taburet A.M., Cohen-Codar I., Van P.N., Chauvin J.P. Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients. AIDS 2008, 22:385-393.
6. Eddy E.M. HSP70-2 heat-shock protein of mouse spermatogenic cells. J. Exp. Zool. 1998, 282:261-271.
7. Larder B.A., Kemp S.D., Harrigan P.R. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 1995, 269:696-699.
8. Ling J.Y., Zhang G.Y., Cui Z.J., Zhang C.K. Supercritical fluid extraction of quinolizidine alkaloids from Sophora flavescens Ait. and purification by high-speed counter-current chromatography. J. Chromatogr. A 2007, 1145:123-127.
9. Lu L.G., Zeng M.D., Mao Y.M., Li J.Q., Wan M.S., Li C.Z., Chen C.W., Fu Q.C., Wang J.Y., She W.M., Cai X., Ye J., Zhou Q.X., Wang H., Wu S.M., Tang M.F., Zhu J.S., Chen W.X., Zhang H.Q. Capsule oxymatrine in the treatment of chronic hepatitis B: a randomized double blind placebo controlled multicenter study (I). Chin. Hepatol. 2002, 7:218-221.
10. Lu L.G., Zeng M.D., Mao Y.M., Li J.Q., Wan M.B., Li C.Z., Chen C.W., Fu Q.C., Wang J.Y., She W.M., Cai X., Ye J., Zhou X.Q., Wang H., Wu S.M., Tang M.F., Zhu J.S., Chen W.X., Zhang H.Q. Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial. World J. Gastroenterol. 2003, 9:2480-2483.
11. Mohanty S.R., Kupfer S.S., Khiani V. Treatment of chronic hepatitis B. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:446-458.
12. Parent R., Qu X., Petit M.A., Beretta L. The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity. Hepatology 2009, 49:1798-1809.
13. Peng Z.G., Fan B., Du N.N., Wang Y.P., Gao L.M., Li Y.H., Li Y.H., Liu F., You X.F., Han Y.X., Zhao Z.Y., Cen S., Li J.R., Song D.Q., Jiang J.D. Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA. Hepatology 2010, 52:845-853.
14. Prange R., Werr M., Löffler-Mary H. Chaperones involved in hepatitis B virus morphogenesis. Biol. Chem. 1999, 380:305-314.
15. Price P.M., Banerjee R., Acs G. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:8541-8544.
16. Shafer R.W. Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin. Microbiol. Rev. 2002, 15:247-277.
17. Wang B.E. Treatment of chronic liver diseases with traditional Chinese medicine. J. Gastroenterol. Hepatol. 2000, 15(Suppl.):67-70.
18. Wang Y., Menggen D., Zheng W.Y., Wu H.S., Liu S.D. Pharmacokinetics of oxymatrine in patients with chronic hepatitis B. Chin. J. Clin. Pharm. 2003, 12:228-230.
19. Wang Y.P., Liu F., He H.W., Han Y.X., Peng Z.G., Li B.W., You X.F., Song D.Q., Li Z.R., Yu L.Y., Cen S., Hong B., Sun C.H., Zhao L.X., Shao R.G., Jiang J.D. Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus. Antimicrob. Agents Chemother. 2010, 54:2070-2077.
20. Yao G.B., Ji Y.Y., Wang Q.H., Zhou X.Q., Xu D.Z., Chen X.Y. A randomized double-blind controlled trial of bicyclol in treatment of chronic hepatitis B. Chin. J. New Drugs Clin. Rem. 2002, 21:457-462.
21. Yu Y., Si C., Zeng Z., Wang Q., Zhou X., Zhang Q., Huang Z., Zhang L., Qiao G. A clinical trial of oxymatrine in treating chronic viral hepatitis type B. Chin. J. Int. Med. 2001, 40:843-846.
22. Yuan M.F., Fung J., Wong D.K.H., Lai C.L. Prevention and management of drug-resistance for antihepatitis B treatment. Lancet Infect. Dis. 2009, 9:256-264.
23. Zhang J., Hou T., Wang W., Liu J.S. Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1321-1326.
24. Zhao K.K., Miao X.H., Xu W.S. Quantitative detection of hepatitis B virus cccDNA in infected hepatocytes. Chin. J. Infect. Dis. 2005, 23:6-9.
25. Zoulim F., Durantel D., Deny P. Management and prevention of drug resistance in chronic hepatitis B. Liver Int. 2009, 29(s1):108-115.